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Background: Atypical infectious agents have been proposed as potential contributors to
asthma. A novel set of morphological and staining criteria permit the identification of flagel-
lated protozoa in sputum. This case-control study was designed to use this novel method
and to assess: (1) are protozoa more common in asthmatics than in non-asthmatics; (2) is
the presence of protozoa associated with the use of steroid inhalers; and (3) is the presence
of protozoa associated with living in damp housing?
Methods: Induced sputum samples were collected from asthma patients and local non-atopic,
non-smoking controls. Questionnaires assessed asthma severity and housing conditions.
Sputum was examined for flagellated protozoa using a previously described staining technique.
Results: 96 participants were recruited for this study; 54 asthma patients and 42 controls, age
range 21e62 years, 70% female participants. Limiting results to those who were clearly positive
or negative for flagellated protozoa, 66.7% (20/30) of asthmatics and 30.8% (4/13) of controls
had protozoa (pZ 0.046). Among the asthma patients, prevalence of protozoa was not signif-
icantly different between those who had (10/18), and those who had not (10/12), used steroid
inhaler in the preceding two weeks (p Z 0.11). Similarly, the prevalence of protozoa was not
significantly different between those who did (6/11) and those who did not (18/32), live in
damp homes (p Z 0.92).
Conclusions: This case-control study demonstrates an association between flagellated
protozoa in sputum and asthma. It is now necessary to confirm and characterise the protozoaHealth Sciences, St George’s University of London, Cranmer Terrace, London, SW17 0RE, UK.
0807599.
.ac.uk (H.C. van Woerden).
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878 H.C. van Woerden et al.using genetic techniques based on 18S ribosomal RNA. Once tis is established it would be
worthwhile to determine if asthma symptoms improve when treated by anti-protozoal agents.
ª 2010 Elsevier Ltd. All rights reserved.Background
A wide range of aetiological factors have been suggested as
possible causes of asthma1,2 including the hygiene hypothesis3
which postulated that differential exposure to infectious
agents might have an aetiological role in asthma. Viral infec-
tions of the respiratory tract are widely accepted as an
important factor in acute exacerbations of asthma4,5 and some
authors have suggested that asthmamay even be an infectious
disease.6 There is growing interest in the potential contribu-
tion of a number of atypical infectious agents to the aetiology
of asthma, particularly Mycoplasma and Chlamydia.4,7,8
A number of case series have previously demonstrated
the presence of flagellated protozoa in the sputum of
patients with respiratory symptoms admitted to hospitals in
Spain andWales with acute exacerbations of disease9e11 and
in patients who were immuno-compromised.12,13 These
studies have demonstrated that flagellated protozoa are
present in a proportion of respiratory patients, particularly
those with asthma, when using a set of staining techniques
that have not previously been utilised in the field of sputum
cytology to identify protozoa. Another reason why flagel-
lated protozoa have not been widely recognised in sputum
samples is that flagellated protozoa are easily mistaken for
ciliated epithelial cells.14 The cyto-pathologists involved in
this study have described a set of morphological and staining
criteria to differentiate flagellated protozoa from ciliated
cell fragments.9,10
It is unclear whether the protozoa observed in the respi-
ratory case series above are more common in patients with
asthma than healthy controls; whether their presence is
related to other factors such as the use of steroid inhalers; or
whether their presence is related to living in damp home
conditions. It can be argued that steroid inhalers could
dampen the immune system and facilitate the growth of
commensal protozoa. Dampness, mould and other indoor bio-
aerosols have also been associated with a variety of respira-
tory symptoms including Building Related Illnesses, and bio-
aerosols including microbes, fungi, viruses, protozoa, pollens,
dander and mite-related debris are present in indoor air in
significant quantities.15e17 The smaller sized particles in a bio-
aerosol remain airborne for long periods of time, and also fall
within the respirable size fraction. It was therefore, consid-
ered important to consider whether living in a damp homewas
associated with the presence of protozoa in sputum.
This case-control study was designed to test three
hypotheses arising from these considerations: (1) are
protozoa more prevalent in asthmatics than in non-asth-
matics, (2) is the presence of protozoa associated with the
use of steroid inhalers, and (3) is the presence of protozoa
associated with living in damp housing?
Methods
Asthma patients and control subjects were recruited from
two GP practices in Battersea, south west London and fromWandsworth Primary Care Trust, south west London.
Control subjects were non-smokers who did not have
a history of asthma, eczema, or hay fever. For this study
the definition of asthma was: physician diagnosed asthma,
currently under active management by the patient’s GP, as
recorded in the practice’s computer records.
To recruit asthma patients, a letter was sent to all the
patients on the asthma register of both GP practices
explaining the study design and inviting them to participate.
Notices were also placed in the waiting rooms of the GP’s
surgeries inviting individuals who did not smoke and who did
not have asthma, eczema or hay fever to volunteer as
controls. Some participants were recruited by word of
mouth. Patients and control subjects were paid a small
amount in recognition of the time involved in participating in
the study. Participants were subsequently asked to complete
a questionnaire gathering demographic details, oral or
inhaled steroid use in the preceding two weeks, and asthma
symptoms in the preceding two weeks. A previously pub-
lished asthma score, AS-218 was used to assess the severity of
asthma. This score is based on four questions: Howmany days
did you cough in the past 2 weeks? How many days were you
wheezy in the past 2 weeks? Howmany dayswere you short of
breath in the past 2 weeks? How many days were you awak-
ened at night due to your asthma in the past 2 weeks? The
questions are marked on a scale of 1e4, where 1 is “Not at
all”, 2 is 1e3 days, 3 is 4e7 days and a score of 4 is 8e14 days.
The average score of the four questions forms the AS-2 score.
The presence of damp in the home was assessed using
a previously published score.19 This score incorporates four
questions: Is there any visible mould growth on your house? Is
there any odour of mould or cellar-like fusty air in your
house? Is there anymoisture stains in your house? Is there any
water/moisture damage in your house? A positive answer to
any of these questions was taken to indicate a “damp” home.
Participants then attended a clinic held at their GP
surgery where an induced sputum sample was collected. Any
individuals who had been on oral steroids in the preceding
twoweeks, or had suffered from a respiratory tract infection
in the preceding two weeks, or who had a baseline Peak
Expiratory Flow Rate (PEFR) of less than 70% their predicted
value (based on gender, height and age)were asked to return
at a later date. A standard protocol, using normal saline
(0.9%) as the nebulised solution, was used to induce sputum
production based on widely used sputum induction meth-
ods.20e23 Participants were pre-medicated with three puffs
of Salbutamol via a spacer device to reduce the risk of
inducing bronchospasm. Peak flows (best of three attempts)
were checked at 30 s, 2 min, 6 min, 10 min, 14 min, and
18 min, giving a maximum nebulisation time of 18 min.
Nebulisation was stopped after a shorter interval if an
adequate sputum sample had been produced. The procedure
was terminated if the peak flow fell by 20% of the baseline
PEFR, if the participant becamewheezy, or if the participant
wished at any point to terminate the procedure. Sputum
samples were collected in sterile petri dishes. Samples were
considered adequate when at least two or more opaque,
Figure 1 Selecting sputum, as opposed to saliva, using the
pick technique.
Association between asthma and protozoa in sputum 879muco-cellular clumps at least 1.5  3.0 mm in size had been
collected.22,24 Samples of true sputum (not saliva), were
taken from the petri dish using sterile disposable tweezers to
minimise salivary contamination of the samples using
a standard ‘pick technique’ (Fig. 1). The sputum sample was
placed on a microscope slide and, a second slide was used to
make a smooth, uniform smear, gently moving both slides in
opposite directions, without exerting undue pressure. The
two microscope slides obtained from each participant were
immediately fixed using Cytofix spray. The microscope
slides were stained using previously described techniques9
and examined for the presence of flagellated protozoa by
a cyto-pathologist using a previously described set of
morphological criteria.9,10,14 All the slides were scanned in
a systematic manner under the microscope. Slides that had
only scanty squamous cells or scantywhite cells were classed
as ‘inadequate’ as it was presumed that these slides con-
tained little true sputum. Differential cell counts were
calculated for each individual in the study based on a sample
of 100 cells. Duplicate countswere undertaken on a subset of
the samples to confirm the accuracy of the initial cell counts.
Fig. 2 provides an example of degenerative phenomena inFigure 2 Degenerative changes in ciliated bronchial cells
(Magnification  1000).ciliated bronchial cells and Fig. 3 provides an example of
protozoa in the sputum of a patient with asthma, although
not a participant in this study.
Participantswere informed if protozoawere found in their
sputum, although they were advised that the significance of
this finding was currently unknown. Any willing participants,
particularly those with protozoa, were invited to re-attend
the clinic on more than one occasion to provide an additional
induced sputum sample.
For the purposes of statistical analysis, participants who
had sputum collected on more than one occasion were
classed as “positive for protozoa” if protozoa were detec-
ted on any occasion. Participants were particularly
encouraged to return to provide another sample where the
first sample was classified as “inadequate” or “unclear”.
This was because participants’ technique improved over
time, and better quality sputum samples were often
produced at the second visit. To assess whether our colla-
tion of the positive results was reasonable, a sensitivity
analysis was undertaken using only sputum collected at the
first visit. This did not materially change the direction of
any finding, although the smaller sample size reduced the
statistical significance of the findings (data not shown).
Data were entered and analysed using SPSS 14 for
Windows. EpiInfo Version 6 was used to calculate Fisher’s
Exact Test. The study protocol was approved by Camden
and Islington community local research ethics committee
(Reference 08/H0722/540).
Results
Demographic data
A total of 96 individuals, 15 male and 39 female asthma
patients, and 14 male and 28 female controls subjects
participated in the study. There were no significant
differences between the mean age of asthma patients
(39.4 yrs; range 16e64 yrs) and the mean age of controls
(37.1 yrs; range 21e62 yrs). Amongst the asthma patients,
87% (47 individuals) were non-smokers, 7.4% (4 individuals)Figure 3 Flagellated protozoa from the sputum of an asthma
patient clearly demonstrating the presence of “capitullum”
and irregular flagella (Magnification  1000).
Table 1 Summary of the presence or absence of protozoa in study participants.
Protozoa
present
Protozoa
absent
Unclear whether
protozoa present
Inadequate
sample (saliva)
No sputum
obtained
Total
Asthma patients 20 10 3 1 20 54
Controls 4 9 2 0 27 42
Total 24 19 5 1 47 96
880 H.C. van Woerden et al.were current smokers, and 5.6% (3 individuals) were ex-
smokers. Control subjects were selected based on being
non-smokers and having a low probability of being atopic,
by using a set of screening questions to identify a history of
asthma, eczema and hay fever. None of the control
subjects had asthma, although in five cases the information
available could not fully exclude the possibility of previous
eczema or hay fever. The 96 participants made 137 visits to
the clinic and attempts to collect sputum were successful in
58.4% of attempts (80/137).
A breakdown of the results in patients and controls is
provided in Table 1. One participant withdrew from the
study, and nebulisation was stopped in one patient who
became wheezy. There was one inadequate sample, where
only saliva rather than muco-cellular content was present
on the microscope slides. In five cases, the cyto-pathologist
was uncertain over the presence or absence of protozoa in
the sample provided. Forty-six participants did not produce
any sputum. Protozoa were identified in 20 asthma patients
and 4 control subjects.
No statistically significant relationship was observed
between the presence or absence of protozoa and the
proportion of eosinophils, monocytes/macropages or
neutrophils observed in sputum smears when the differ-
ences were assessed using the ManneWhitney test.
Were protozoa more common in asthmatics than in
non-asthmatics?
The prevalence of protozoa in asthma patients was 66.7%
(20/30) and in controls, it was 30.8% (4/13). Fisher’s Exact
Test comparing the proportion of asthma patients and
control subjects in which protozoa were clearly ‘present’ or
‘absent’ gave a p value of 0.046, relative risk of 1.58 (95% CI
1.00e2.51). The data supports the hypothesis that protozoa
are more prevalent in patients diagnosed with asthma than
in comparable controls.Table 2 Comparison of the presence or absence of
protozoa against the use of a steroid inhaler in the
preceding two weeks, among 30 asthma patients.
Protozoa in sputum Total
Yes No
Have you taken a
steroid/preventative
inhaler in the last
2 weeks?
Yes 10 8 18
No 10 2 12
Total 20 10 30Was the presence of protozoa associated with the
use of steroid inhalers?
To determine whether the presence of protozoa was asso-
ciated with the use of steroid inhalers, we compared the
proportion of asthma patients with and without protozoa in
their sputum against self-reported use of a steroid inhaler in
the preceding two weeks. The prevalence of protozoa in the
sputum of asthma patients who had not used a steroid
inhaler in the preceding two weeks (83%, 10/12), was higher
than the prevalence in those who had used a steroid inhaler
in the preceding two weeks (55.5%, 10/18). However, this
difference was not statistically significant (chi-square 2.50,
p Z 0.114). See Table 2. These findings do not support the
hypothesis that an increased prevalence of protozoa in
sputum is associated with recent use of steroid inhalers.
Was the presence of protozoa associated with living
in a damp home?
The presence or absence of protozoa in sputum was
compared against the presence of damp in the home. The
score was dichotomised (‘no evidence of damp’ against ‘any
evidence of damp’) as it had been in the paper from which
this set of questions were taken. See Table 3. Analysis was
limited to those who had clear positive or negative result for
protozoa in their sputum. The prevalence of protozoa was
not significantly different between those who did (54.5%, 6/
11) and thosewho did not (56.3%, 18/32), live in damp homes
(p Z 0.92). In summary, the data do not support the
hypothesis that an increased prevalence of protozoa in
sputum is associated with living in damp housing.
Over what duration did protozoa persist in the
sputum of an individual?
Some information was obtained on the duration over which
protozoa persist in the sputum of an individual. Table 4
summarises the information on 12 participants who hadTable 3 Comparison of the presence or absence of
protozoa against evidence of damp/mouldy in the home.
Protozoa in sputum Total
Yes No
No evidence
of damp/mould
18 14 32
Evidence
of damp/mould
6 5 11
Total 24 19 43
Table 4 Observed duration of the presence of protozoa in
participants.
Patient or Control First visit Later visit Interval (days)
Asthma patient Protozoa Protozoa 103
Asthma patient Protozoa Protozoa 88
Asthma patient Protozoa Protozoa 80
Asthma patient Protozoa Protozoa 46
Asthma patient Protozoa Protozoa 37
Asthma patient Protozoa Protozoa 17
Asthma patient Protozoa Protozoa 14
Asthma patient Protozoa Protozoa 8
Asthma patient Protozoa Protozoa 2
Asthma patient Protozoa Protozoa 2
Asthma patient Protozoa Protozoa 2
Control Protozoa Protozoa 18
Association between asthma and protozoa in sputum 881sputum samples taken on two separate visits to the clinic.
The mean interval between the two visits was 34.75 days
(range 2e103 days).
Three patients had protozoa in their sputum at one visit
but not at the other visit. The change in PEFR before
induced sputum was collected, comparing the two visits,
was around 10 l/min in all three cases, with the higher PEFR
readings occurring on the occasions when protozoa were
identified. This sample size is too small to determine
whether asthma symptoms were significantly different but
merits further investigation in a larger sample.
Do symptoms and PEFR differ between asthma
patients with and without protozoa in their
sputum?
To assess whether protozoa were more likely to be present in
the milder or more severely affected asthma patients, the
distribution of the AS-2 asthma scores in those asthma
patients who had, and thosewhodid not have, protozoawere
compared. Themedian AS-2 score in those with protozoawas
1.25 and in those without protozoa the median score was
1.75. The ManneWhitney U statistic was 59.5, p Z 0.068.
Although the asthma patients with protozoa in their sputum
generally had milder asthma than those who did not have
protozoa, the difference was not statistically significant.
The relationship between peak flow and the presence or
absence of protozoa in the sputum of asthma patients was
assessed using the ManneWhitney test, with equal vari-
ances not assumed. There was no relationship between
peak flow (best of three blows at the start of the proce-
dure) and the presence of protozoa (p Z 0.252). Similarly,
there was no relationship between the presence or absence
of protozoa and the lowest peak flow recorded during the
sputum induction procedure (p Z 0.14).
Discussion
This case-control study demonstrates an association between
the presence of protozoa in induced sputum samples and
a previous GP diagnosis of asthma. No association was found
between the presence of protozoa and the use of steroid
inhalersor thepresenceofprotozoaand living indamphousing.The prevalence of protozoa in asthma patients (66.7%)
was broadly similar to that seen in a previous Spanish
study.9 The Spanish study also examined patients with
other respiratory diseases, mostly COPD, but did not study
health controls.
Asthma may represent a cluster of conditions with
similar symptoms2,25 and it is possible to speculate that the
presence of protozoa represents a relatively mild infection
which produces asthma like symptoms. The relatively high
proportion of non-asthmatic individuals who had protozoa
in their sputum also suggests that in many individuals these
protozoal organisms do not have a pathogenic role.
However, a number of recent papers have demonstrated
that a range of organisms are present in the healthy lung
but are more common in COPD or asthma.26,27 There is
clearly growing interest in the role of infective organisms in
asthma, but their role and significance is still unclear.
However, it is possible to speculate that the protease
enzymes that protozoa produce could act in the same way
as Der P1 to breakdown the tight junctions between
epithelial cells, increase the shedding of epithelial cells in
the respiratory tract, and facilitate the penetration of
allergens into local tissues. It is also possible to speculate
that degenerative remnants from the cytoplasm or cell
membrane from dead protozoa could act as an ‘adjuvant’,
magnifying the immune response to concomitantly pre-
sented allergens.28e30 If asthma is viewed as a symptom
cluster caused by range of underlying aetiologies, respira-
tory tract infection with protozoa could be a contributory
factor in a subset of asthma patients.
Comparing the demographic characteristics of patients
and controls does not suggest that our approach to the
recruitment of cases and controls has introduced significant
bias. In addition, the cyto-pathologist examining the
sputum samples was blinded as to whether each sample
came from an asthma patient or a control subject. Analysis
of data was also undertaken independent of data
collection.
The main weakness of the study is its relatively small
size. The study would also have been strengthened by
further classification of asthma, including a more
detailed assessment as to whether patients had intrinsic
or extrinsic asthma and an assessment of other end points
such as exhaled nitric oxide levels. The study could have
been strengthened by having the sputum slides examined
by two independent cyto-pathologists, as the character-
istics used to define the presence or absence of protozoa,
have not been externally validated by an independent
laboratory. Consequently, we currently have no estimate
of the false positive or false negative rate for the
assessment of the microscope slides by our cyto-
pathologist.
We chose to use normal saline in the ultrasonic nebuliser
as it tastes more pleasant and is less likely to trigger
bronchospasm.22,24 This may have contributed to the rela-
tively low proportion of control patients in whom sputum
was obtained (35.7%, 15/42). The proportion of participants
who produced sputum might have been higher had we had
used hypertonic saline. If the prevalence of protozoa in the
sputum of those control participants from whom sputum
was not obtained was zero, then the incidence of protozoa
could have been as low as 9.5% (4/42). It is possible to
Appendix 1. Instructions for obtaining sputum
smears
1. The sputum should be deposited in a sterile container.
2. A small area of true sputum (not saliva), about the size
of a large lentil, should be taken from the expectora-
tion using tweezers and scissors.
Step 1
Step 2
882 H.C. van Woerden et al.speculate that the control subjects who did not produce
any sputum after nebulisation may have been less atopic
and had lower bronchial reactivity. Similarly, further
testing (for example, by skin prick tests) of the four
controls that had protozoa to detect any underlying atopic
tendency would have been helpful.
It is possible for induced sputum samples to be
contaminated by oral microbiota. However, a study
comparing the bacteria present in oral, induced sputum and
bronchial lavage samples taken from the same individuals
has provided some reassurance that this is not a major
issue27 The ‘pick technique’ that we have used should also
have ensured that most of the material smeared across
a slide comes from the inside of the gelatinous sputum
globules that were individually picked up and placed on
microscope slides. Although the surface of such globules
would have some contact with saliva, this would only form
a small proportion of each sputum sample as each sample
was smeared on a microscope slide. There is evidence that
protozoa live in the biofilms that form dental plaque.31e33
As the oral and respiratory mucosa form one continuous
surface, it is clearly possible that there could be a link
between oral and respiratory tract protozoa.
Conclusions
This case-control study supports the hypothesis that the
presence of protozoa in sputum is statistically associ-
ated with a clinical diagnosis of asthma. It provides
sufficient evidence to suggest that this hypothesis
requires further exploration to determine whether these
organisms are playing any primary or secondary patho-
genic role, or whether their presence is merely an
incidental finding.
It would be helpful if the organisms could be charac-
terised using molecular techniques, for example, based on
the characterisation of 18s RNA, as at present the species of
protozoa observed is unknown and we cannot determine
whether the same species of organism is present in
different samples. Once this is established, a trial of anti-
protozoal agents would also be worthwhile, to determine
whether asthma symptoms improve when these protozoa
are killed by an anti-protozoal agent. Similarly, trials of
antibiotics have been used to assess the impact of the
treatment of Chlamydia infection in patients with
asthma.34
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3. Place the sample on a slide (frosted edge upwards) and,
with a second slide (frosted edge downwards) make
a smooth, uniform smear. It is not appropriate to crush
the sample, but rather to move both slides in opposite
directions, exerting slight pressure. To facilitate this
operation, take the frosted edge of each slide between
thumb and forefinger.Acknowledgements
We are grateful to the two GP practices that assisted us in
this study: Battersea Fields Practice, and Lavender HillGroup Practice, and also to Wandsworth PCT who funded
the study.
Step 3
Step 4
4. Immediately fix the smears on both slides with
commercially available hair lacquer, spraying the whole
surface from a distance of approximately 30 cm. Make
sure to spray the surface of the slides where the smears
are (that corresponding to the frosted area of the edges).
Before introducing the fixed slides into their containers
for dispatch, leave them face up for a while until certain
that none of the material seeps out at the sides.
Step 5
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